April 2013

The Part D coverage gap reform in 2011 improved adherence to diabetes medications in the coverage gap.

This article outlines strategies insurers can use to mitigate their risks related to prescription opioid abuse by members, while addressing this serious public health problem.

We estimated the long-term risks and benefits of disease modifying therapies. Benefits were favored by natalizumab with minimal increased risks in the negative anti-JC virus population.

Health plans are fundamentally transforming the delivery of healthcare for patients by reforming payment models, coordinating care, and partnering with providers.

Perceived barriers and benefits to implementing disease management programs among Israeli healthcare leaders could assist other countries faced with increasing numbers of chronically ill patients.

Use of online shared records was higher among HIV patients who had indicators of recent increases in healthcare needs and lower among several vulnerable populations.

Retail clinic use is associated with lower overall total cost of care based on a matched-pair analysis.

More comprehensive discussion of colorectal screening by primary care physicians was associated with higher screening rates among adults aged 51 to 80 years who were overdue for screening.

This study explores self-reported reasons for primary nonadherence among patients newly prescribed statin medication in an integrated health delivery system.

When controlling for maternal and hospital factors, cesarean delivery rates increased more rapidly for privately versus publicly funded births, with important cost and health implications.